Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Arginine N-Methyltransferases | 2 | 2024 | 34 | 0.250 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2025 | 34 | 0.230 |
Why?
|
| Methyltransferases | 1 | 2025 | 78 | 0.220 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2024 | 11 | 0.220 |
Why?
|
| Abortion, Induced | 1 | 2025 | 89 | 0.200 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 420 | 0.170 |
Why?
|
| T-Lymphocytes | 3 | 2025 | 1722 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 229 | 0.160 |
Why?
|
| Tumor Escape | 1 | 2021 | 65 | 0.160 |
Why?
|
| Herpesvirus 2, Gallid | 1 | 2018 | 2 | 0.140 |
Why?
|
| Marek Disease | 1 | 2018 | 2 | 0.140 |
Why?
|
| Poultry Diseases | 1 | 2018 | 5 | 0.140 |
Why?
|
| Ultracentrifugation | 1 | 2018 | 20 | 0.140 |
Why?
|
| Circulating MicroRNA | 1 | 2018 | 12 | 0.140 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2018 | 52 | 0.140 |
Why?
|
| Exosomes | 1 | 2018 | 60 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 317 | 0.130 |
Why?
|
| Population Health | 1 | 2017 | 35 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 274 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 713 | 0.120 |
Why?
|
| Vaccines | 1 | 2017 | 388 | 0.090 |
Why?
|
| Shigella | 1 | 2012 | 4 | 0.090 |
Why?
|
| Genomics | 1 | 2021 | 1621 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 3748 | 0.090 |
Why?
|
| Genes, Bacterial | 1 | 2012 | 215 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2012 | 166 | 0.080 |
Why?
|
| Virulence Factors | 1 | 2012 | 180 | 0.080 |
Why?
|
| Neoplasms | 2 | 2024 | 3016 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2012 | 697 | 0.070 |
Why?
|
| Animals | 6 | 2025 | 33912 | 0.060 |
Why?
|
| Mice | 4 | 2025 | 18301 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2024 | 43 | 0.050 |
Why?
|
| Australia | 1 | 2025 | 173 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2023 | 18 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 4738 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2023 | 175 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2023 | 435 | 0.040 |
Why?
|
| Self Report | 1 | 2025 | 554 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2024 | 446 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2021 | 23 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1490 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 272 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 155 | 0.040 |
Why?
|
| Marek Disease Vaccines | 1 | 2018 | 1 | 0.040 |
Why?
|
| Chickens | 1 | 2018 | 267 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2024 | 807 | 0.030 |
Why?
|
| Vaccine Potency | 1 | 2017 | 9 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2026 | 0.030 |
Why?
|
| Humans | 8 | 2025 | 131163 | 0.030 |
Why?
|
| Epidemics | 1 | 2017 | 58 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2021 | 760 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 1833 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1928 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 311 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2017 | 155 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2326 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 768 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2017 | 362 | 0.030 |
Why?
|
| Female | 4 | 2025 | 70963 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 558 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 2012 | 234 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 135 | 0.020 |
Why?
|
| Pregnancy | 1 | 2025 | 7512 | 0.020 |
Why?
|
| Vaccination | 1 | 2017 | 1060 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 300 | 0.020 |
Why?
|
| Virulence | 1 | 2012 | 268 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 599 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 10103 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 526 | 0.020 |
Why?
|
| Androstane-3,17-diol | 1 | 1988 | 1 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3385 | 0.020 |
Why?
|
| Androstanols | 1 | 1988 | 8 | 0.020 |
Why?
|
| Hair | 1 | 1988 | 30 | 0.020 |
Why?
|
| Acne Vulgaris | 1 | 1988 | 25 | 0.020 |
Why?
|
| Lipectomy | 1 | 1986 | 8 | 0.020 |
Why?
|
| Lymphangioma | 1 | 1986 | 21 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 20987 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1986 | 909 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1988 | 24 | 0.000 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1988 | 19 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1988 | 101 | 0.000 |
Why?
|
| Thorax | 1 | 1988 | 63 | 0.000 |
Why?
|
| Testosterone | 1 | 1988 | 531 | 0.000 |
Why?
|
| Adult | 2 | 1988 | 31282 | 0.000 |
Why?
|
| Male | 1 | 1988 | 64957 | 0.000 |
Why?
|